Compound ID | 3059
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, and Enterobacter cloacae, but not active against Gram-positives; targets the lipoprotein transport system |
| Description: | Synthetic compound; derived by combining pyridinepyrazole and pyridineimidazole and further modified to improve accumulation in Gram-negative; shows no activity against Gram-negative gut commensals; reduces bacterial burden by 3-log when administered orally in mice infected with colistin-resistant Escherichia coli; no activity against |
| Year first mentioned: | 2024 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Guide to Pharmacology: | lolamicin |
| Citation: | https://www.nature.com/articles/s41586-024-07502-0 |